• Guideline Summary
  • NGC:009079
  • 2012 Feb

Pharmalgen for the treatment of bee and wasp venom allergy.

  • Guideline Summary
  • NGC:009852
  • 2005 Jan (revised 2013 Jun)

Recommendations on screening for depression in adults.

  • Guideline Summary
  • NGC:009375
  • 2012 Oct

Psoriasis: the assessment and management of psoriasis.

  • Guideline Summary
  • NGC:010540
  • 2013 Aug

EGFR-TK mutation testing in adults with locally advanced or metastatic non-small-cell lung cancer.

  • Guideline Summary
  • NGC:010917
  • 2016 Feb 17

Major trauma: service delivery.

  • Guideline Summary
  • NGC:009073
  • 2003 Oct (revised 2012 Apr)

Dasatinib, nilotinib and standard-dose imatinib for the first-line treatment of chronic myeloid leukaemia (part review of technology appraisal guidance 70).

  • Guideline Summary
  • NGC:010022
  • 1998 Oct (revised 2013 Sep)

Treatment of primary breast cancer. A national clinical guideline.

  • Guideline Summary
  • NGC:010900
  • 2016 Feb 10

Myeloma: diagnosis and management.

  • Guideline Summary
  • NGC:010812
  • 2012

Patient blood management guidelines: module 4 - critical care.

  • Guideline Summary
  • NGC:009196
  • 2012 Jun

Sickle cell acute painful episode: management of an acute painful sickle cell episode in hospital.

  • Guideline Summary
  • NGC:009893
  • 2013 May

Bevacizumab in combination with gemcitabine and carboplatin for treating the first recurrence of platinum-sensitive advanced ovarian cancer.

  • Guideline Summary
  • NGC:009800
  • 2013 April

Percutaneous vertebroplasty and percutaneous balloon kyphoplasty for treating osteoporotic vertebral compression fractures.

  • Guideline Summary
  • NGC:010016
  • 2006 Oct (revised 2013 Sep)

Urinary incontinence: the management of urinary incontinence in women.

  • Guideline Summary
  • NGC:010204
  • 2003 Jun (revised 2014 Jan)

Head injury. Triage, assessment, investigation and early management of head injury in children, young people and adults.

  • Guideline Summary
  • NGC:009748
  • 2013 Mar

Hyperphosphataemia in chronic kidney disease. Management of hyperphosphataemia in patients with stage 4 or 5 chronic kidney disease.